Home » Topics » Conferences

Conferences
RSS

ICAAC presentation for potent new anti-HCMV agent from RPR with novel mechanism of action

Oct. 1, 1998

Twice-daily Viracept as safe and effective as the approved t.i.d. schedule

Oct. 1, 1998

Major pediatric study supports safety and efficacy of pneumococcal vaccine

Oct. 1, 1998

Aviron presents new clinical data for FluMist at ICAAC

Oct. 1, 1998

IB-367: preclinical results presented at ICAAC support clinical trials in oral mucositis

Sep. 30, 1998

Potent, broad-spectrum, orally active 2-pyridone antibacterial enters Abbott pipeline

Sep. 30, 1998

Valaciclovir therapy suppresses viral shedding in patients with genital herpes

Sep. 30, 1998

Carbapenems in development at Korean research institute characterized at ICAAC

Sep. 30, 1998

SYN-2869: new triazole antifungal agent selected for further development

Sep. 30, 1998

Yoshitomi optimizes quinolones for anti-H. pylori activity: selects Y-34867 as development candidate

Sep. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...